Literature DB >> 7969051

Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.

C C Kuo1, B P Bean.   

Abstract

The anticonvulsant phenytoin inhibited Na+ currents in rat hippocampal neurons with a potency that increased dramatically at depolarized holding potentials, suggesting weak binding to resting Na+ channels but tight binding to open or inactivated channels. Four different experimental measurements, i.e., steady block at different holding potentials, on and off kinetics at depolarized holding potentials, shifts in the inactivation curve, and dose-dependent slowing of recovery from inactivation, yielded an estimated Kd of approximately 7 microM for phenytoin binding to inactivated channels. Prolonged depolarizations of at least several seconds were necessary for significant block by therapeutic concentrations of phenytoin. The slow development of block does not reflect selective binding of phenytoin to slow inactivated states of the channel, because block developed faster and required less depolarized voltages than did slow inactivation. Instead, it appears that phenytoin binds tightly but slowly (approximately 10(4) M-1 sec-1) to fast inactivated states of the Na+ channels. This tight but slow binding may underlie the ability of phenytoin to disrupt epileptic discharges with minimal effects on normal firing patterns.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969051

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  55 in total

1.  Quantification of state-dependent drug interactions with the sodium channel.

Authors:  R D Sheridan
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.

Authors:  Gregory M Lipkind; Harry A Fozzard
Journal:  Mol Pharmacol       Date:  2010-07-19       Impact factor: 4.436

3.  Mutant bacterial sodium channels as models for local anesthetic block of eukaryotic proteins.

Authors:  Natalie E Smith; Ben Corry
Journal:  Channels (Austin)       Date:  2016-02-06       Impact factor: 2.581

4.  An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+.

Authors:  Ya-Chin Yang; Chung-Chin Kuo
Journal:  J Gen Physiol       Date:  2005-04-11       Impact factor: 4.086

Review 5.  Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons.

Authors:  Anthony M Rush; Theodore R Cummins; Stephen G Waxman
Journal:  J Physiol       Date:  2006-12-07       Impact factor: 5.182

6.  Molecular basis of differential sensitivity of insect sodium channels to DCJW, a bioactive metabolite of the oxadiazine insecticide indoxacarb.

Authors:  Weizhong Song; Zhiqi Liu; Ke Dong
Journal:  Neurotoxicology       Date:  2005-12-02       Impact factor: 4.294

7.  Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine.

Authors:  Xin Qiao; Guangchun Sun; Jeffrey J Clare; Taco R Werkman; Wytse J Wadman
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

8.  Structural determinants of drugs acting on the Nav1.8 channel.

Authors:  Liam E Browne; Frank E Blaney; Shahnaz P Yusaf; Jeff J Clare; Dennis Wray
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

9.  Modulation of sodium channel inactivation gating by a novel lactam: implications for seizure suppression in chronic limbic epilepsy.

Authors:  Paulianda J Jones; Ellen C Merrick; Timothy W Batts; Nicholas J Hargus; Yuesheng Wang; James P Stables; Edward H Bertram; Milton L Brown; Manoj K Patel
Journal:  J Pharmacol Exp Ther       Date:  2008-10-24       Impact factor: 4.030

10.  Electrophysiological actions of phenytoin on N-methyl-D-aspartate receptor-mediated responses in rat hippocampus in vitro.

Authors:  A J Laffling; P Scherr; J G McGivern; L Patmore; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.